Inactive Instrument
Quotes Merrimack Pharmaceuticals
Stocks
MACK
US5903282094
Biotechnology & Medical Research
Stock exchange
Nasdaq
MACK 15.13 $
-.--%
1.9Cr
$
| Markets | Price | Change | Volumes |
|---|
Performance
| 3 years | +22.91% | ||
| 5 years | +242.31% | ||
| 10 years | -73.27% |
Volumes
marketsCapital turnover ratio
0.03
Float rotation
0.03
Basic data
Market Cap (USD)
22,37,48,022
Number of employees
27
Sales / Employee ()
0
Sales / Employee (USD)
0
Free-Float
98.81%
Free-Float capitalization (USD)
22,10,82,736
Average Daily Capital Traded
3.39%
Indicators
Moving average 5 days
15.12
Moving average 20 days
14.95
Moving average 50 days
14.81
Moving average 100 days
14.3
Price spread / (MMA5)
-0.07%
Price spread / (MMA20)
-1.19%
Price spread / (MMA50)
-2.12%
Price spread / (MMA100)
-5.49%
RSI 9 days
82.79
RSI 14 days
78.97
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | -.--% | +22.91% | 22Cr | |
| -0.62% | -1.87% | +46.31% | +56.99% | 6.38TCr | |
| +0.35% | +3.20% | +14.92% | +84.55% | 5.64TCr | |
| +0.53% | +1.96% | +15.37% | +106.81% | 5.46TCr | |
| -2.81% | -4.31% | +23.50% | +50.90% | 4.41TCr | |
| -0.33% | -1.93% | +20.15% | +98.45% | 4.21TCr | |
| +0.55% | +2.31% | +224.97% | +942.56% | 4.1TCr | |
| +3.27% | +47.96% | +112.67% | +96.48% | 3.49TCr | |
| +1.22% | -1.44% | +14.89% | +47.15% | 3.28TCr | |
| +0.89% | +20.55% | -42.03% | +373.03% | 2.47TCr | |
| Average | +0.31% | +7.54% | +43.07% | +187.98% | 3.95TCr | |
| Weighted average by Cap. | +0.18% | +5.44% | +48.47% | +186.04% |
Historical Quotes: Merrimack Pharmaceuticals
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Price Extremes
| 3 years | 12 |  | 15.89 |
| 5 years | 3 | | 15.89 |
| 10 years | 1.49 | | 67.9 |
Monthly variations
Annual variations
| 2024 | +12.83% | ||
| 2023 | +17.02% | ||
| 2022 | +193.09% | ||
| 2021 | -43.25% | ||
| 2020 | +118.73% | ||
| 2019 | -18.39% | ||
| 2018 | -62.34% | ||
| 2017 | -74.88% | ||
| 2016 | -48.35% | ||
| 2015 | -30.09% | ||
| 2014 | +111.97% | ||
| 2013 | -12.46% | ||
| 2012 | +0.83% |
